CF Patients' COVID antibodies tracked in new study
NCT ID NCT04992234
First seen Feb 02, 2026 · Last updated Apr 29, 2026 · Updated 11 times
Summary
This study followed 113 people with cystic fibrosis (CF) over two years to see how many had antibodies from COVID-19 infection or vaccination. Researchers collected blood samples and health data to understand if CF patients are less likely to get COVID-19 and how their immune system responds. The goal is to learn more about COVID-19 in this group, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Karolinska University Hospital
Huddinge, Sweden
-
Sahlgrenska University Hospital
Gothenburg, Sweden
Conditions
Explore the condition pages connected to this study.